The University of Pisa, officially founded in 1343, is one of the oldest and most prestigious universities both in Italy and in Europe.

During the past decade, University of Pisa conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 2 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Pisa" #1 sponsor was "University of Pisa" with 15 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Angiodynamics, Inc." with 1 trials sponsored, "AqueSys, Inc." with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pisa" #1 collaborator was "Associazione Medici Diabetologi (AMD)" with 1 trials as a collaborator, "Associazione Nazionale Medici Cardiologi Ospedalieri" with 1 trials as a collaborator, "Biocompatibles UK Ltd" with 1 trials as a collaborator, "Istituto di Fisiologia Clinica CNR" with 1 trials as a collaborator and "The Champalimaud Centre, Lisbon, Portugal" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "University of Pisa" are "Type 2 Diabetes" (3 trials), "Child, Only" (2 trials), "Ovarian Cancer" (2 trials), "Albuminuria" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "University of Pisa" in a lesser frequency.

Most popular intervention types in "University of Pisa" are "Drug" (8 trials), "Device" (5 trials), "Other" (5 trials), "Procedure" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Autologous connective tissue graft with rotated papilla flap" (1 trials), "Cataract Surgery" (1 trials), "Collagen matrix construct (Mucograft)" (1 trials), "Cytoreductive surgery" (1 trials) and "Dapagliflozin 10 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Pisa" are 26 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Pisa". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in University of Pisa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Pisa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".